ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gastroesophageal Reflux Disease Therapeutics Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-28P13312
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Gastroesophageal Reflux Disease Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Gastroesophageal Reflux Disease Therapeutics Market Research Report 2025

Code: QYRE-Auto-28P13312
Report
September 2025
Pages:71
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astrazeneca plc
Eisai Co Ltd
Takeda Pharmaceutical
GlaxoSmithKline PLC
Johnson & Johnson
Daewoong Pharmaceutical
Ironwood Pharmaceuticals
Johnson & Johnson

Gastroesophageal Reflux Disease Therapeutics Market Size

The global market for Gastroesophageal Reflux Disease Therapeutics was valued at US$ 4649 million in the year 2024 and is projected to reach a revised size of US$ 4166 million by 2031, growing at a CAGR of -1.6% during the forecast period.

Gastroesophageal Reflux Disease Therapeutics Market

Gastroesophageal Reflux Disease Therapeutics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gastroesophageal Reflux Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastroesophageal Reflux Disease Therapeutics.
The Gastroesophageal Reflux Disease Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastroesophageal Reflux Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastroesophageal Reflux Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gastroesophageal Reflux Disease Therapeutics Market Report

Report Metric Details
Report Name Gastroesophageal Reflux Disease Therapeutics Market
Accounted market size in year US$ 4649 million
Forecasted market size in 2031 US$ 4166 million
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Antacids
  • H2 Receptor Blockers
  • Proton Pump Inhibitors (PPIs)
  • Pro-kinetic Agents
  • Others
Segment by Application
  • Hospital Pharmacy
  • Drug Stores
  • General Stores
  • Supermarkets
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AstraZeneca, Eisai, Takeda Pharmaceutical, GlaxoSmithKline, Johnson & Johnson, Daewoong Pharmaceutical, Ironwood Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Gastroesophageal Reflux Disease Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

What is the Gastroesophageal Reflux Disease Therapeutics Market size in 2031?

Ans: The Gastroesophageal Reflux Disease Therapeutics Market size in 2031 will be US$ 4166 million.

Who are the main players in the Gastroesophageal Reflux Disease Therapeutics Market report?

Ans: The main players in the Gastroesophageal Reflux Disease Therapeutics Market are AstraZeneca, Eisai, Takeda Pharmaceutical, GlaxoSmithKline, Johnson & Johnson, Daewoong Pharmaceutical, Ironwood Pharmaceuticals

What are the Application segmentation covered in the Gastroesophageal Reflux Disease Therapeutics Market report?

Ans: The Applications covered in the Gastroesophageal Reflux Disease Therapeutics Market report are Hospital Pharmacy, Drug Stores, General Stores, Supermarkets

What are the Type segmentation covered in the Gastroesophageal Reflux Disease Therapeutics Market report?

Ans: The Types covered in the Gastroesophageal Reflux Disease Therapeutics Market report are Antacids, H2 Receptor Blockers, Proton Pump Inhibitors (PPIs), Pro-kinetic Agents, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antacids
1.2.3 H2 Receptor Blockers
1.2.4 Proton Pump Inhibitors (PPIs)
1.2.5 Pro-kinetic Agents
1.2.6 Others
1.3 Market by Application
1.3.1 Global Gastroesophageal Reflux Disease Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Drug Stores
1.3.4 General Stores
1.3.5 Supermarkets
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastroesophageal Reflux Disease Therapeutics Market Perspective (2020-2031)
2.2 Global Gastroesophageal Reflux Disease Therapeutics Growth Trends by Region
2.2.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gastroesophageal Reflux Disease Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Gastroesophageal Reflux Disease Therapeutics Market Dynamics
2.3.1 Gastroesophageal Reflux Disease Therapeutics Industry Trends
2.3.2 Gastroesophageal Reflux Disease Therapeutics Market Drivers
2.3.3 Gastroesophageal Reflux Disease Therapeutics Market Challenges
2.3.4 Gastroesophageal Reflux Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastroesophageal Reflux Disease Therapeutics Players by Revenue
3.1.1 Global Top Gastroesophageal Reflux Disease Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Gastroesophageal Reflux Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gastroesophageal Reflux Disease Therapeutics Revenue
3.4 Global Gastroesophageal Reflux Disease Therapeutics Market Concentration Ratio
3.4.1 Global Gastroesophageal Reflux Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastroesophageal Reflux Disease Therapeutics Revenue in 2024
3.5 Global Key Players of Gastroesophageal Reflux Disease Therapeutics Head office and Area Served
3.6 Global Key Players of Gastroesophageal Reflux Disease Therapeutics, Product and Application
3.7 Global Key Players of Gastroesophageal Reflux Disease Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastroesophageal Reflux Disease Therapeutics Breakdown Data by Type
4.1 Global Gastroesophageal Reflux Disease Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Type (2026-2031)
5 Gastroesophageal Reflux Disease Therapeutics Breakdown Data by Application
5.1 Global Gastroesophageal Reflux Disease Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gastroesophageal Reflux Disease Therapeutics Market Size (2020-2031)
6.2 North America Gastroesophageal Reflux Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2020-2025)
6.4 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastroesophageal Reflux Disease Therapeutics Market Size (2020-2031)
7.2 Europe Gastroesophageal Reflux Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2020-2025)
7.4 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size (2020-2031)
9.2 Latin America Gastroesophageal Reflux Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Gastroesophageal Reflux Disease Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025)
11.1.5 AstraZeneca Recent Development
11.2 Eisai
11.2.1 Eisai Company Details
11.2.2 Eisai Business Overview
11.2.3 Eisai Gastroesophageal Reflux Disease Therapeutics Introduction
11.2.4 Eisai Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025)
11.2.5 Eisai Recent Development
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Company Details
11.3.2 Takeda Pharmaceutical Business Overview
11.3.3 Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Introduction
11.3.4 Takeda Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025)
11.3.5 Takeda Pharmaceutical Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Introduction
11.4.4 GlaxoSmithKline Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025)
11.4.5 GlaxoSmithKline Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Introduction
11.5.4 Johnson & Johnson Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025)
11.5.5 Johnson & Johnson Recent Development
11.6 Daewoong Pharmaceutical
11.6.1 Daewoong Pharmaceutical Company Details
11.6.2 Daewoong Pharmaceutical Business Overview
11.6.3 Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Introduction
11.6.4 Daewoong Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025)
11.6.5 Daewoong Pharmaceutical Recent Development
11.7 Ironwood Pharmaceuticals
11.7.1 Ironwood Pharmaceuticals Company Details
11.7.2 Ironwood Pharmaceuticals Business Overview
11.7.3 Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Introduction
11.7.4 Ironwood Pharmaceuticals Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025)
11.7.5 Ironwood Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Astrazeneca plc
Eisai Co Ltd
Takeda Pharmaceutical
GlaxoSmithKline PLC
Johnson & Johnson
Daewoong Pharmaceutical
Ironwood Pharmaceuticals
Johnson & Johnson
List of Tables
 Table 1. Global Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Antacids
 Table 3. Key Players of H2 Receptor Blockers
 Table 4. Key Players of Proton Pump Inhibitors (PPIs)
 Table 5. Key Players of Pro-kinetic Agents
 Table 6. Key Players of Others
 Table 7. Global Gastroesophageal Reflux Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Region (2020-2025)
 Table 11. Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Region (2026-2031)
 Table 13. Gastroesophageal Reflux Disease Therapeutics Market Trends
 Table 14. Gastroesophageal Reflux Disease Therapeutics Market Drivers
 Table 15. Gastroesophageal Reflux Disease Therapeutics Market Challenges
 Table 16. Gastroesophageal Reflux Disease Therapeutics Market Restraints
 Table 17. Global Gastroesophageal Reflux Disease Therapeutics Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Players (2020-2025)
 Table 19. Global Top Gastroesophageal Reflux Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease Therapeutics as of 2024)
 Table 20. Ranking of Global Top Gastroesophageal Reflux Disease Therapeutics Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Gastroesophageal Reflux Disease Therapeutics Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Gastroesophageal Reflux Disease Therapeutics, Headquarters and Area Served
 Table 23. Global Key Players of Gastroesophageal Reflux Disease Therapeutics, Product and Application
 Table 24. Global Key Players of Gastroesophageal Reflux Disease Therapeutics, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type (2020-2025)
 Table 28. Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type (2026-2031)
 Table 30. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Application (2020-2025)
 Table 32. Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Application (2026-2031)
 Table 34. North America Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 49. AstraZeneca Company Details
 Table 50. AstraZeneca Business Overview
 Table 51. AstraZeneca Gastroesophageal Reflux Disease Therapeutics Product
 Table 52. AstraZeneca Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 53. AstraZeneca Recent Development
 Table 54. Eisai Company Details
 Table 55. Eisai Business Overview
 Table 56. Eisai Gastroesophageal Reflux Disease Therapeutics Product
 Table 57. Eisai Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 58. Eisai Recent Development
 Table 59. Takeda Pharmaceutical Company Details
 Table 60. Takeda Pharmaceutical Business Overview
 Table 61. Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Product
 Table 62. Takeda Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 63. Takeda Pharmaceutical Recent Development
 Table 64. GlaxoSmithKline Company Details
 Table 65. GlaxoSmithKline Business Overview
 Table 66. GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Product
 Table 67. GlaxoSmithKline Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 68. GlaxoSmithKline Recent Development
 Table 69. Johnson & Johnson Company Details
 Table 70. Johnson & Johnson Business Overview
 Table 71. Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Product
 Table 72. Johnson & Johnson Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 73. Johnson & Johnson Recent Development
 Table 74. Daewoong Pharmaceutical Company Details
 Table 75. Daewoong Pharmaceutical Business Overview
 Table 76. Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Product
 Table 77. Daewoong Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 78. Daewoong Pharmaceutical Recent Development
 Table 79. Ironwood Pharmaceuticals Company Details
 Table 80. Ironwood Pharmaceuticals Business Overview
 Table 81. Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Product
 Table 82. Ironwood Pharmaceuticals Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 83. Ironwood Pharmaceuticals Recent Development
 Table 84. Research Programs/Design for This Report
 Table 85. Key Data Information from Secondary Sources
 Table 86. Key Data Information from Primary Sources
 Table 87. Authors List of This Report


List of Figures
 Figure 1. Gastroesophageal Reflux Disease Therapeutics Picture
 Figure 2. Global Gastroesophageal Reflux Disease Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Type: 2024 VS 2031
 Figure 4. Antacids Features
 Figure 5. H2 Receptor Blockers Features
 Figure 6. Proton Pump Inhibitors (PPIs) Features
 Figure 7. Pro-kinetic Agents Features
 Figure 8. Others Features
 Figure 9. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Application: 2024 VS 2031
 Figure 11. Hospital Pharmacy Case Studies
 Figure 12. Drug Stores Case Studies
 Figure 13. General Stores Case Studies
 Figure 14. Supermarkets Case Studies
 Figure 15. Gastroesophageal Reflux Disease Therapeutics Report Years Considered
 Figure 16. Global Gastroesophageal Reflux Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Gastroesophageal Reflux Disease Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Region: 2024 VS 2031
 Figure 19. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Players in 2024
 Figure 20. Global Top Gastroesophageal Reflux Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease Therapeutics as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Gastroesophageal Reflux Disease Therapeutics Revenue in 2024
 Figure 22. North America Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Gastroesophageal Reflux Disease Therapeutics Market Share by Country (2020-2031)
 Figure 24. United States Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Gastroesophageal Reflux Disease Therapeutics Market Share by Country (2020-2031)
 Figure 28. Germany Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Share by Region (2020-2031)
 Figure 36. China Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Gastroesophageal Reflux Disease Therapeutics Market Share by Country (2020-2031)
 Figure 44. Mexico Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Share by Country (2020-2031)
 Figure 48. Turkey Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. AstraZeneca Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025)
 Figure 52. Eisai Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025)
 Figure 53. Takeda Pharmaceutical Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025)
 Figure 54. GlaxoSmithKline Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025)
 Figure 55. Johnson & Johnson Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025)
 Figure 56. Daewoong Pharmaceutical Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025)
 Figure 57. Ironwood Pharmaceuticals Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Gastro Esophageal Reflux Disease GERD Drug Market Research Report 2025
Gastroesophageal Reflux Disease GERD Diagnosis Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Proton Pump Inhibitor Drug Market Research Report 2025
Global Still s Disease Treatment Market Research Report 2025
Comprehensive Medicine for Esophageal Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptic Ulcers Treatment Market Research Report 2024
Ophthalmology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inflammatory Bowel Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Proton Therapy Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inflammatory Bowel Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Treatment Planning Software Market Research Report 2025
Idiopathic Pulmonary Fibrosis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diagnostic Guidewire Market Research Report 2024
Global Cardiovascular Disease Nursing Drugs Market Research Report 2025
Pulmonary Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Digital Health and Digital Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Combination Therapy Drug Market Research Report 2025
Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmerging Market Research Report 2025
Prescription Dermatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions